Lead party: Essam Abdelhadi (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Nawah Scientific Inc. (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: Egypt
Transaction type: Investment · Asset class: Venture Capital · Strategy: Strategic Minority · Instrument: Equity
Lead investor/buyer: Essam Abdelhadi · Investors/buyers: Essam Abdelhadi
Legal advisers: not identified in the source record.
Source: announced 18 October 2021. Original announcement: old.disruptafrica.com.


